L&C Bio

290650.KQ

41.99 USD

-3.18

-7.04%

Overview

Last close

41.99 usd

Market cap

1.16B usd

52 week high

81.75 usd

52 week low

14.37 usd

Target price

64.43 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

13.3602

Price/Book Value

3.6992

Enterprise Value

906.18M usd

EV/Revenue

10.521

EV/EBITDA

12.6876

Key financials

Revenue TTM

86.13M usd

Gross Profit TTM

50.53M usd

EBITDA TTM

20.31M usd

Earnings per Share

-4.02 usd

Dividend

0.04 usd

Total assets

308.51M usd

Net debt

14.34M usd

About

L&C BIO Co.,LTD operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C BIO Co.,LTD was founded in 2011 and is headquartered in Seongnam-si, South Korea.

Symbol
290650.KQ
Exchange
KQ
Isin
KR7290650001
Country
South Korea
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Chul Lee Whan
Headquarter
Seongnam-si
Web site
https://www.lncbio.co.kr

Related indices

JAKOTA Mid and Small Cap 2000 Index

201.65 -2.49%